Hasil Filter

23

Total database: 17430
Struktur (SMILES)
16 (69.6%)
Target
16 (69.6%)
Genomik
1 (4.3%)
Referensi
23 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (23)

small molecule | CAS: 628290-43-7

GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.

Target Protein:
DNA topoisomerase 2-alphaDNA
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Aldoxorubicin DB06013
small molecule | CAS: 1361644-26-9

Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.

Kategori:
AnthracyclinesAntineoplastic AgentsCarbohydrates +4
Target Protein:
DNA topoisomerase 2-alphaDNA topoisomerase 2-beta
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Annamycin DB06420
small molecule | CAS: 92689-49-1

Deskripsi belum tersedia.

Kategori:
AnthracyclinesAntibiotics, AntineoplasticAntineoplastic Agents +4
Target Protein:
DNA topoisomerase 2-alphaDNA
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AVA-6000 DB17398
small molecule | CAS: 1841402-73-0

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Batabulin DB16103
small molecule | CAS: 195533-53-0

Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients).

Kategori:
AmidesBenzene DerivativesHydrocarbons, Fluorinated +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Camsirubicin DB13103
small molecule | CAS: 236095-29-7

GPX-150 has been used in trials studying the treatment of Soft Tissue Sarcoma and Advanced Solid Tumors - Phase 1 Population.

Kategori:
AnthracyclinesCarbohydratesGlycosides +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Diazepinomicin DB12420
small molecule | CAS: 733035-26-2

Diazepinomicin has been used in trials studying the treatment of Glioblastoma Multiforme. It is a proprietary first-in-class small molecule with the potential to treat multiple solid tumours like the well known chemotherapeutics, doxorubicin and mitomycin C. …

Kategori:
Heterocyclic Compounds, Fused-RingTerpenes
Target Protein:
Translocator protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Doxorubicin Approved DB00997
small molecule | CAS: 23214-92-8

Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius along side with daunorubicin, another cytotoxic agent, in 1970.[A1575,A257709,A257614] Although they both have aglyconic and sugar moieties, doxo…

Kategori:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related Substances +36
Target Protein:
DNA topoisomerase 2-alphaTelomerase reverse transcriptaseDNA +3
Gen Terkait:
RARG SLC28A3 UGT1A6
Waktu ParuhThe terminal half-l…
Vol. DistribusiThe steady-state di…
KlirensThe plasma clearanc…
Genetik 3 Varian
DTS-201 DB06071
small molecule

DTS-201 is a prodrug of doxorubicin, a widely used anti-cancer drug that Diatos intends to develop for the treatment of various solid tumors. It is activated in the tumor environment. DTS-201 may be suitable for the treatment of many types of solid tumors, i…

Kategori:
AnthracyclinesCarbohydratesGlycosides +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Epcoritamab Approved DB16672
biotech | CAS: 2134641-34-0

Epcoritamab is an IgG1-bispecific antibody that simultaneously binds to CD3 on T-cells and CD20 on B-cells.[A259736,A258488,A259761,L46516] Epcoritamab promotes the activation and expansion of T-cells and, by being able to bind to both CD20 and CD3, it leads …

Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntibodies, Monoclonal, Humanized +13
Target Protein:
B-lymphocyte antigen CD20T-cell surface glycoprotein CD3 epsilon chain
Waktu ParuhA full dose of epco…
Vol. DistribusiEpcoritamab has an …
KlirensA full dose of epco…
Genetik -
Epirubicin Approved DB00445
small molecule | CAS: 56420-45-2

An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.

Kategori:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related Substances +17
Target Protein:
DNA topoisomerase 2-betaDNADNA topoisomerase 2-alpha
Waktu ParuhHalf-lives for the …
Vol. Distribusi* 21 ± 2 L/kg [60 m…
Klirens* 65 +/- 8 L/hour […
Genetik -
Glofitamab Approved DB16371
biotech | CAS: 2229047-91-8

Glofitamab is a full-length bispecific monoclonal antibody with affinity for both CD20 and CD3 surface antigens found on B- and T-cells, respectively. It has a 2:1 configuration, with bivalency towards CD20 and monovalency towards CD3, and works by recruiting…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +10
Target Protein:
B-lymphocyte antigen CD20T-cell surface glycoprotein CD3
Waktu ParuhThe transition from…
Vol. DistribusiFollowing intraveno…
KlirensGlofitamab's serum …
Genetik -
Mifamurtide Approved DB13615
small molecule | CAS: 83461-56-7

Mifamurtide is an immunomodulator with antitumor activity via activation of macrophages and monocytes. Also called L-MTP-PE, mifamurtide may be a liposomal form of of the active ingredient MTP-PE, which is a synthetic, less pyrogenic, and longer-acting deriva…

Kategori:
Adjuvants, ImmunologicAmino Acids, Peptides, and ProteinsAmino Sugars +15
Target Protein:
Toll-like receptor 4Nucleotide-binding oligomerization domain-containing protein 2
Waktu ParuhFollowing intraveno…
Vol. DistribusiThe mean volume of …
KlirensThe clearance from …
Genetik -
Nerofe DB14786
small molecule | CAS: 1311294-45-7

Nerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS).

Kategori:
Amino Acids, Peptides, and Proteins
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nolatrexed DB12912
small molecule | CAS: 147149-76-6

Nolatrexed is under investigation in clinical trial NCT00012324 (Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer).

Kategori:
AntimetabolitesAntineoplastic AgentsEnzyme Inhibitors +5
Target Protein:
Thymidylate synthase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Olaratumab Approved DB06043
biotech | CAS: 1024603-93-7

Olaratumab (IMC-3G3) is a fully human IgG1 monoclonal antibody with antitumor activity that selectively binds the external domain of human platelet-derived growth factor receptor (PDGFR)-? with high affinity and blocks ligand binding. It is composed of two he…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +12
Target Protein:
Platelet-derived growth factor receptor alpha
Waktu ParuhEstimated value of …
Vol. Distribusi7.7 L at steady sta…
KlirensMean value of 0.56L…
Genetik -
Pirarubicin DB11616
small molecule | CAS: 72496-41-4

Deskripsi belum tersedia.

Kategori:
AnthracyclinesAnthracyclines and Related SubstancesAntineoplastic Agents +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Pixantrone Approved DB06193
small molecule | CAS: 144510-96-3

Pixantrone is an aza-anthracenedione and DNA intercalator which inhibits topoisomerase II. It is similar in structure to anthracyclines such as mitoxantrone, but exerts fewer toxic effects on cardiac tissue. [2] The lower cardio-toxic effects of pixantrone ma…

Kategori:
Anthracyclines and Related SubstancesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +6
Target Protein:
DNA topoisomerase 2-alphaDNA topoisomerase 2-beta
Waktu ParuhHalf life ranges fr…
Vol. Distribusi9.7-29.7 L/kg. [2]
KlirensPlasma clearance is…
Genetik -
SGN-15 DB05818
biotech

SGN-15 is studied in the treatment of cancer. It combines a monoclonal antibody with the anticancer drug doxorubicin. Monoclonal antibodies are substances that are made in the laboratory and that can locate and bind to cancer cells. Doxorubicin is a type of a…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
SP1049C DB04978
small molecule

SP1049C is a novel anthracycline chemotherapeutic agent containing [doxorubicin] and two nonionic pluronic block copolymers.[A260416] It is designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. Phase 2 resu…

Kategori:
AlcoholsAnthracyclinesCarbohydrates +8
Target Protein:
DNA topoisomerase 2-alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tesmilifene DB04905
small molecule | CAS: 98774-23-3

Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.

Kategori:
Antiplatelet agentsBenzene DerivativesCytochrome P-450 CYP2D6 Substrates +18
Target Protein:
ATP-dependent translocase ABCB1Histamine H1 receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valrubicin Approved DB00385
small molecule | CAS: 56124-62-0

Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the [doxorubicin], which is an anthracycline drug. Used in the treatment of the bladder cancer, valrub…

Kategori:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related Substances +9
Target Protein:
DNADNA topoisomerase 2-betaDNA topoisomerase 2-alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 139570-93-7

Zoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.

Kategori:
Amino Acids, Peptides, and ProteinsAnthracyclinesCarbohydrates +12
Target Protein:
Gonadotropin-releasing hormone receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -